We are live on
!
Find out more
AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
1-Year Est. Return
31.17%
This Fund
S&P 500
This Quarter
Est. Return
-23.26%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$75.7M
AUM Growth
-$11.3M
(-13%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
20.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Annexon
ANNX
|
+$14.6M |
| 2 |
Akebia Therapeutics
AKBA
|
+$852K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCP
AFA
MCC
SGL
MC
OAM
IP
JCP
Alerce Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, Alerce Investment Management held 6 positions worth $75.7M, down 13% from $86.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alerce Investment Management deployed $15.4M of net new capital in Q1 2023, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Alerce Investment Management added most to Annexon in Q1 2023, an estimated $14.6M increase.
- Alerce Investment Management's ten largest holdings make up 100% of its $75.7M portfolio in Q1 2023.
- Alerce Investment Management opened 0 new positions and closed 0 in Q1 2023.
- Alerce Investment Management's portfolio value fell 13% quarter-over-quarter to $75.7M.
Based on Alerce Investment Management's 13F filing for Q1 2023, filed 15 May 2023.